The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein
Hypoxia-inducible transcription factors (HIFs) drive angiogenesis and cancer cell growth, contributing to an aggressive tumor phenotype. HIF-α protein levels and activity are controlled at the post-translational level by HIF hydroxylases. Hydroxylated HIF-α is recognized by the von Hippel Lindau (VH...
Main Authors: | Christina Wohlrab, Margreet C. M. Vissers, Elisabeth Phillips, Helen Morrin, Bridget A. Robinson, Gabi U. Dachs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00574/full |
Similar Items
-
Selective HIF2A Inhibitors in the Management of Clear Cell Renal Cancer and Von Hippel–Lindau-Disease-Associated Tumors
by: Cristina Suárez, et al.
Published: (2023-06-01) -
Investigation and Management of Apparently Sporadic Central Nervous System Haemangioblastoma for Evidence of Von Hippel–Lindau Disease
by: Hugh Furness, et al.
Published: (2021-09-01) -
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
by: Kenan Ashouri, et al.
Published: (2015-09-01) -
Novel genotype–phenotype correlations in five Chinese families with Von Hippel–Lindau disease
by: Qiuli Liu, et al.
Published: (2018-06-01) -
A Review of Von Hippel-Lindau Syndrome
by: Neha Varshney, et al.
Published: (2017-08-01)